sequence stringlengths 4 17.9k | seq_id stringlengths 1 6 | pn stringclasses 996
values | title stringclasses 871
values | pbdt int64 20.2M 20.3M | status int64 1 225 ⌀ | family_country listlengths 1 55 | modified_info stringlengths 112 8.31k ⌀ |
|---|---|---|---|---|---|---|---|
caacagcauagucaaauaaaa | 684 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caacagcauagucaaauaaaa | 1082 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
taaagcactttattgagtttctg | 39 | JP2025072558A | Oral delivery of oligonucleotides | 20,250,509 | 2 | [
"JP",
"AU",
"US",
"WO",
"EP",
"CA"
] | null |
taaagcactttattgagtttctg | 39 | JP2025072558A | オリゴヌクレオチドの経口送達 | 20,250,509 | 2 | [
"JP",
"AU",
"US",
"WO",
"EP",
"CA"
] | null |
taaagcactttattgagtttctg | 37 | JP2025072558A | Oral delivery of oligonucleotides | 20,250,509 | 2 | [
"JP",
"AU",
"US",
"WO",
"EP",
"CA"
] | null |
taaagcactttattgagtttctg | 37 | JP2025072558A | オリゴヌクレオチドの経口送達 | 20,250,509 | 2 | [
"JP",
"AU",
"US",
"WO",
"EP",
"CA"
] | null |
cuugaaagccuccuagaagaa | 441 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 1067 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 1429 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuugaaagccuccuagaagaa | 811 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauucgauguugaauuaaugucc | 1300 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauucgauguugaauuaaugucc | 895 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauucgauguugaauuaaugucc | 1662 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uauucgauguugaauuaaugucc | 525 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaucuuuguuuuccgggauugc | 566 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaucuuuguuuuccgggauugc | 1690 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaucuuuguuuuccgggauugc | 936 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaucuuuguuuuccgggauugc | 1328 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acaacaaacauuauauugaau | 665 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acaacaaacauuauauugaau | 1110 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acaacaaacauuauauugaau | 295 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acaacaaacauuauauugaau | 1472 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auccauccaacagauucagaa | 418 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auccauccaacagauucagaa | 1144 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auccauccaacagauucagaa | 1506 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auccauccaacagauucagaa | 788 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acuaacuaacuuaauucaaaa | 275 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acuaacuaacuuaauucaaaa | 645 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acuaacuaacuuaauucaaaa | 1081 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
acuaacuaacuuaauucaaaa | 1443 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uugaaugaacugaggcaaauu | 324 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uugaaugaacugaggcaaauu | 1512 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uugaaugaacugaggcaaauu | 694 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uugaaugaacugaggcaaauu | 1150 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaacaagauaauagcaucaa | 429 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaacaagauaauagcaucaa | 1093 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaacaagauaauagcaucaa | 799 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaaacaagauaauagcaucaa | 1455 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caacagcauagucaaauaa | 67 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucaacaaaaagugaaauauu | 334 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucaacaaaaagugaaauauu | 1436 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucaacaaaaagugaaauauu | 704 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucaacaaaaagugaaauauu | 1074 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aggcaaauuuaaaaggcaaua | 1536 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aggcaaauuuaaaaggcaaua | 756 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aggcaaauuuaaaaggcaaua | 386 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aggcaaauuuaaaaggcaaua | 1174 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaccaacagcauagucaaaua | 365 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaccaacagcauagucaaaua | 1064 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaccaacagcauagucaaaua | 735 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aaccaacagcauagucaaaua | 1426 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aguccauggacauuaauucaa | 1096 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aguccauggacauuaauucaa | 785 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aguccauggacauuaauucaa | 1458 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aguccauggacauuaauucaa | 415 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 1666 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 933 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 1304 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auugcauuggggacauugccagu | 563 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
gauuugcuauguuagacga | 57 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uacuucaacaaaaagugaaau | 692 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uacuucaacaaaaagugaaau | 1418 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uacuucaacaaaaagugaaau | 322 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uacuucaacaaaaagugaaau | 1056 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ggcaaauuuaaaaggcaauaa | 1179 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ggcaaauuuaaaaggcaauaa | 771 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ggcaaauuuaaaaggcaauaa | 401 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
ggcaaauuuaaaaggcaauaa | 1541 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aucaaauauguugaguuuuugaa | 876 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aucaaauauguugaguuuuugaa | 1551 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aucaaauauguugaguuuuugaa | 506 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
aucaaauauguugaguuuuugaa | 1189 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auagagaaauuucuguggguucu | 1258 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auagagaaauuucuguggguucu | 872 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auagagaaauuucuguggguucu | 502 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
auagagaaauuucuguggguucu | 1620 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuuguuaaaacucuaaacu | 60 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caacauauuugaucagucuuu | 294 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caacauauuugaucagucuuu | 664 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caacauauuugaucagucuuu | 1018 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
caacauauuugaucagucuuu | 1380 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uagaauuuuuucuucuaggaggc | 485 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uagaauuuuuucuucuaggaggc | 1628 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uagaauuuuuucuucuaggaggc | 855 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uagaauuuuuucuucuaggaggc | 1266 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucaacaucgaauagauggau | 1131 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucaacaucgaauagauggau | 726 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucaacaucgaauagauggau | 356 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uucaacaucgaauagauggau | 1493 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
cuuaaagacuuuguccaua | 41 | US11306316B2 | Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof | 20,220,419 | 3 | [
"RU",
"MX",
"JP",
"AT",
"KR",
"AU",
"CN",
"US",
"CA",
"HK",
"SG",
"ES",
"EP",
"IT",
"BR",
"WO",
"DE",
"MO",
"NZ"
] | null |
uuuaaaucucuucggaaccuu | 278 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uuuaaaucucuucggaaccuu | 278 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uuuaaaucucuucggaaccuu | 513 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uuuaaaucucuucggaaccuu | 513 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uugugagaacuguaguguaacuu | 566 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uugugagaacuguaguguaacuu | 566 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uugugagaacuguaguguaacuu | 313 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
uugugagaacuguaguguaacuu | 313 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gagggucucggccccggccc | 90 | CA3164599A1 | Human chromosome 9 open reading frame 72 (c9orf72) irna agent compositions and methods of use thereof | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
gagggucucggccccggccc | 90 | CA3164599A1 | AGENTS ET COMPOSITIONS D'ARNI CIBLANT C9ORF72 - CADRE DE LECTURE OUVERT 72 SUR LE CHROMOSOME 9 - HUMAIN ET PROCEDES D'UTILISATION | 20,210,617 | 2 | [
"MY",
"IL",
"TW",
"JP",
"PH",
"EA",
"ZA",
"SG",
"NZ",
"CL",
"HK",
"US",
"IN",
"ID",
"AU",
"EP",
"WO",
"VN",
"KR",
"MX",
"BR",
"CN",
"CO",
"CA"
] | null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.